Directory



Subhash Vasudevan

Professor, Signature Research Programme in Emerging Infectious Diseases

Duke-NUS Medical School

Bio

Professor Vasudevan’s unique research and teaching career since 1989 also includes 5 years in a senior management position in a large Swiss pharmaceutical company. He has built an extensive academic network that serves as a significant professional asset and has published more than 150 peer-reviewed articles that have been cited more > 11000 times, with a H-index of 61.

His professional interests include finding better health solutions through bench to bedside research, teaching innovations and public health initiatives to prevent infections. He founded Singapore Advanced Biologics Pte Ltd in 2011 and led Singapore’s first Phase 1b clinical trial to test an antiviral drug in dengue patients in 2013 that has been licensed from NUS.

Education

Doctor of Philosophy

Australian National University, Australia

Bachelor of Science

LaTrobe University, Australia

Browser not supported

Modern websites need modern browsers

To enjoy the full experience, please upgrade your browser

Try this browser